CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June.
Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year, to build on this success and support the testing of even more animals, the company has announced a high impact, co-ordinated campaign to drive awareness that up to 90% of laminitis cases may have an underlying endocrine cause1,2.
Once again, Boehringer is urging veterinary surgeons to carry out free ACTH blood tests on laminitic or foot-sore horses as part of the campaign, which is backed by Redwings, The British Horse Society and World Horse Welfare.
Professor Andy Durham from the Liphook Equine Hospital, where the ACTH tests are performed, said: "We are learning so much from these tests. For example, we are now recognising PPID routinely in laminitic horses and ponies as young as 10 years old, and in the spring when we might expect to see more EMS cases, where veterinary surgeons have also tested for PPID we are seeing both abnormally elevated ACTH and insulin. Unless the PPID is addressed, horses will continue to be at risk of painful recurrent laminitic episodes which is a significant welfare issue to the horse and extremely frustrating for owners."
To participate in the scheme, veterinary surgeons and horse owners can download ACTH blood test vouchers from www.talkaboutlaminitis.co.uk. Attach the voucher to the ACTH sample submission form and the ACTH laboratory fees will not be charged.
Lee Hackett from The British Horse Society said: "Without the 'Talk About Laminitis' initiative and the support of Boehringer Ingelheim, literally thousands of horses may not be receiving the appropriate treatment and management for their laminitis to help prevent recurrence. We hope as many veterinary surgeons as possible get involved this year to continue this welfare success."
To ensure that horse owners are fully aware of the initiative, a PR and advertising campaign in the equine consumer media will start in March. The ad campaign includes an infomercial on Horse & Country TV (SKY Channel 280), with viewer numbers in excess of 450,000 per month.
There will also be a live online broadcast for horse owners on endocrinopathic laminitis presented by David Rendle BVSc MVM CertEM(IntMed) DipECEIM MRCVS, from the Liphook Equine Hospital in Hampshire. The one-hour webinar, which takes place at 8.00pm on Wednesday 10 April, will educate horse owners on how the veterinary profession's understanding of this debilitating and devastating disease has been completely revolutionised over the past five years. It will be followed by an interactive Q&A session when viewers will be able to pose questions for David to answer.
David said: "As our knowledge of the two hormonal diseases responsible for the majority of cases of laminitis improves, veterinary surgeons can offer their clients more comprehensive advice on treatment options to prevent laminitis. For many owners who have struggled with this condition, this is an absolute revelation and has enormous welfare benefits".
Horse owners can register to view the online programme by visiting www.talkaboutlaminitis.co.uk.
To ensure that veterinary surgeons are versed in the most up to date research available, Boehringer Ingelheim will also be hosting a webinar for veterinary professionals at 8.00pm on Wednesday 13th March, presented by Professor Andy Durham BSc BVSc CertEP DEIM DipECEIM MRCVS. The online seminar, 'The laminitis revolution.... An update on our understanding of endocrinopathic causes of laminitis', will entitle the viewer to a downloadable certificate for one hour of CPD. To register, visit www.bi-academy.co.uk. Places are limited, so register early to avoid disappointment. The webinar will also be available to view after the event on demand.
For further information on how you can promote 'Talk About Laminitis' in your practice contact your Boehringer Ingelheim Territory Manager or call 01344 746959
References
1. Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111-117
2. Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123-1127.
Dr. Tracy Hill, a specialist in internal medicine, has joined the Royal (Dick) School of Veterinary Studies, bringing with her expertise in interventional radiology.
Tracy completed a fellowship in interventional radiology and endoscopy at the Animal Medical Centre in New York, will be researching new techniques in this developing field.
She will also work in the clinic at the School's Hospital for Small Animals and as a senior lecturer.
She said: "Interventional radiology is an emerging and expanding area in veterinary medicine. Interventional radiology employs the use of fluoroscopy and endoscopy to enable minimally invasive treatments for diseases in many body systems. These techniques often reduce morbidity, mortality, or cost associated with more invasive procedures. The Dick Vet has been performing interventional cardiac procedures for some time and we are looking to expand this field into treatment of non-cardiac diseases."
Tracy, who carried out her residency in small animal internal medicine at North Carolina State University, where she also completed a PhD, will help the Royal (Dick) School of Veterinary Studies at the University of Edinburgh to provide interventional radiology procedures.
This includes a minimally invasive treatment for certain liver shunts using a procedure only being regularly performed at a handful of veterinary hospitals in the world. In this procedure, fluoroscopic guidance is used to access the abnormal vessels in the abdomen via a catheter placed in the jugular vein in the neck. The abnormal shunt vessel is then closed using coil embolization, without the need for abdominal surgery.
Tracey said: "I am delighted to join the Dick Vet. There is no denying the expertise at the vet school, as well as its partnership with The Roslin Institute for research."
Her Royal Highness, the Princess Royal opened a new ward for canine cancer patients at the University of Edinburgh's Royal (Dick) School of Veterinary Studies Hospital for Small Animals last week.
The Kennel Club Charitable Trust provided £30,000 towards the 26-kennel ward, which is specifically designed to provide recuperative care and comfortable kennelling facilities for dogs at the University's Hospital for Small Animals.
The facilities the new dog ward provides will complement the School's £3 million Riddell-Swan Veterinary Cancer Centre, which opened last year. The cancer care centre houses state-of-the-art equipment including a computerised tomography (CT) scanner and a linear accelerator that can provide radiotherapy treatment.
Caroline Kisko, Secretary of the Kennel Club, said: "The Kennel Club Charitable Trust is extremely pleased that the money it has given to the University of Edinburgh has helped to ensure that its Canine Cancer Care unit could be built.
"The Trust has supported the groundbreaking research being conducted by the University, which is helping to improve our ability to diagnose and treat cancer in dogs, for some time. The Cancer Care Unit will help in a different way, by providing post-treatment and after care for dogs that have been through cancer therapy.
"People love their dogs as a member of their family, so this is a vital part of the care process. It is comforting for them to know that there are comfortable kenneling facilities where their dogs will receive the recuperative care that they need, as well as the potentially life-saving treatment.
"The Charitable Trust has given millions of pounds to projects which help to improve the health and welfare of dogs across the UK. This unit has established the University's place as a leader in conducting not only lifesaving but also life enhancing work for dogs, and the Trust exists precisely to help projects such as this realise their goals."
The canine oncology support ward replaces the old feline ward, and the cats have been moved to a new ward further away from the dogs to help prevent cats from becoming stressed by the noise of barking.
Professor Elaine Watson, Head of the Royal (Dick) School of Veterinary Studies said: "The dog ward, along with our new feline ward enhances the facilities for animals receiving treatment at the School's Hospital for Small Animals and we are very appreciative of the tremendous support from the Kennel Club Charitable Trust."
Vetoquinol has announced that packs of Rubenal 300mg are now available in bottles of 60 tablets instead of the previous 20.
Rubenal, which was launched earlier this year, is a complementary nutritional feeding stuff for the support of renal function in case of chronic renal insufficiency in dogs and cats. It is used as an aid to the maintenance of the normal renal fibrous architecture.
Simon Boulton, Rubenal's product manager said: "This increased pack size is a direct result of customer consultation. It will make treatment more cost effective for dogs and allow a longer treatment period per pack purchased."
For further information please contact your Vetoquinol representative or telephone 0800 1698197.
VetSurgeon member Viki Edmondson MRCVS is taking part in a drive to help 13-year-old Octavia Woodward, who was born with spinal muscular atrophy (SMA), raise £100,000 to help The SMA Trust.
Viki, a well-known vet in the carriage driving world, will be joining Octavia on 'Octavia's Mad Marathon', a five-day, 110 mile carriage drive from Windsor to Wincanton.
Octavia will be driving her pony, Diddy, with her mother Henrietta as co-driver. Meanwhile, Viki will be driving a pair of Gelderlander horses. They'll be leaving the main ring at the Royal Windsor Horse Show with a support crew at 3:30pm on 13th May.
Viki graduated from Bristol Veterinary School in 1993. Since 2001 she has run her own equine practice plus a small animal surgery from the Newdigate, Surrey farm she shares with husband Peter. Viki has known Octavia since she was born and it was Viki who paired up Diddy with Octavia and encouraged her to progress from walking round the roads to the excitement of "off-roading". Viki will be providing support and encouragement to Octavia during the trip - of course with any veterinary help being close by.
To support Viki and Octavia, visit: http://www.justgiving.com/vikithevet
BVA Past President Peter Jones is appearing before an All Party Parliamentary Group (APPG) on Antibiotics today, to update parliamentarians and stakeholders on the efforts the association and the profession are making to tackle the issue. Speaking to the APPG, Peter will say: "We know that the biggest cause of antibiotic resistance in humans is the overuse and misuse of antibiotics in human medicine and this was highlighted in the joint report on resistance from the Department of Health (DoH) and Defra.
"However, we are not complacent about the role of antibiotic use in veterinary medicine and we are one of the leading voices in the campaign for the responsible use of antibiotics in all species.
"We remain committed to the One Health principle and the need for the medical and veterinary professions to work together to tackle antimicrobial resistance. BVA and our specialist divisions are currently working on a plan to deliver the five-year strategy on AMR from the veterinary perspective. The actions being taken have been published along with those of our partners in the RUMA response to the DoH/Defra strategy.
"One of our key aims for the strategy will be to promote the importance of evidence-based responsible use among both vets and their clients. We are already encouraging education on minimising resistance and principles of responsible use through engagement with the veterinary schools and other stakeholders, and through our own continuing professional development (CPD) programme.
"The use of antibiotics in veterinary medicine in Europe in the future may well be different to how we have used them in the past, with certain constraints on certain classes of critically important medicines used in man. We will cooperate in adapting to this new environment but any changes must be based on sound scientific risk analysis and not on misrepresentation of the evidence, or at worse falsification of that evidence."
Another key action for BVA is the updating of BVA's responsible use guidance for the veterinary profession, and BVA's species divisions continue to work on advice tailored to their particular sectors.
BVA is also continuing to call for quicker, cheaper and more accessible accurate sensitivity and pen-side testing for veterinary use, and repeated this call in recent submissions to the Science & Technology Select Committee and the APPG on Eggs, Pigs and Poultry.
BVA has also agreed in principle that antibiotic use should be recorded and reported and will consider how such recording and reporting may be encouraged, how usage may be measured and audited, and how prescribing habits can be assessed. Such measures will help us to monitor trends in resistance development and track the progress we can make in addressing the problem.
81% of equine worming strategies are not effective in fight against resistance, because owners are not conducting an adequate level of faecal egg counts (FEC), according to a survey carried out by Countrywide, the supplier of equestrian products.
The company surveyed nearly 1,000 horse owners in collaboration with Westgate Laboratories, Norbrook and BW Equine Vets and found that 47% have never conducted an FEC test.
When asked about their current approach to worming, 59% of respondents said they worm at set times of the year with only 31% conducting regular FEC tests.
Mark Hawkins, SQP at Countrywide, said: "With worms becoming resistant to some worming drugs, simply dosing all horses with routine wormers is not adequate. A targeted approach, which considers each horse as an individual, is needed."
Gillian Booth owner at Westgate Laboratories said: "The results show that the majority of horse owners are not updating their worming practice to match the increase in resistance and improvement in testing technology. Previous worming practices have led to the resistance problems we now have so it is vital that there is change."
The survey found that veterinary surgeons and in store advisors are vital to promote change - 65% of respondents actively seek advice from their vet and Suitably Qualified Person (SQP) for worming and general health care.
Mark added: “A huge 99% of people worm their horse at least once a year; despite this 38% of horse owners do not know an accurate weight of their horse. Considering inaccurate dosing plays a large role with the increase in resistance this figure is very concerning. If you do need to treat, accurate dosing is essential.”
The survey found that 86% of respondents had wormed for tapeworm, making it the most wormed for parasite. Despite this, only 6% of horse owners had conducted a saliva test for tapeworm, and only 8% had conducted the more established ELISA blood test through their vet to prove the need for this worming dose.
For a full breakdown of the survey results, visit: www.countrywidefarmers.co.uk/wormingsurvey.
The campaign will highlight things that can be done to help anxious pets, including getting professional advice from a behaviourist or trainer and using the company's products.
There's a marketing pack for practices, to help you educate owners and promote the month. It includes bunting, wall displays, posters, leaflets and gift vouchers for pet owners.
To raise awareness, Ceva will also be running a PR and advertising campaign together with a social media initiative in which owners will be encouraged to share their experience of having an anxious pet on Instagram and Facebook.
Abigail King, senior product manager at Ceva said: "It is widely known that humans suffer from anxieties, but pets do too with 82% of dogs and 89% of cats reported to be scared of something1.
"It is therefore important that we educate pet owners on the signs of stress and the help and support that they can give to their pets.
"Pet Anxiety Month will get people talking and we want people to know that there are products out there to support pets and that help is at hand to get the right advice, which is extremely important."
For further information, visit the Pet Anxiety Month website or follow the campaign on Instagram and Facebook. To request the Pet Anxiety Month marketing pack, email cevauk@ceva.com.
Reference
She said: “My theme will be focussed on recruitment and particularly widening participation, as one of the three themes of the RCVS Workforce Action Plan.
"I want to get out during my presidential year and talk to school children and teachers, especially head teachers at their conferences, to make them aware of the opportunities that are available to a veterinary science graduate.
“I want to continue to work with the Veterinary Schools Council’s Widening Participation Vet Schools Network to make school children from all backgrounds aware, whether they are from a large, single-sex private school, or a mixed-faith inner-city comprehensive, that veterinary science is accessible to them.
“A veterinary science degree equips graduates with the appropriate skillset to follow a myriad of different career paths.
"For example, in clinical practice caring for people’s beloved pets or working with farmers to produce high-welfare food in an economical and sustainable way. Not to mention groundbreaking research into human and animal diseases, public health to help safeguard food security, the pharmaceutical industry to develop new and innovative treatments, and the armed forces to maintain the health and welfare of military working animals. I could go on.
“As professions, and this means not just veterinary surgeons but veterinary nurses, we need to get out there and sell ourselves to the wider public.
"We have made a start, but we need to become more inclusive and diverse.
"We need to do some myth-busting about the real requirements needed to be a vet or vet nurse.
"There is no doubt you do need to have good A levels to study veterinary medicine, but, beyond that, bright students from any background can join our professions.
"You can be a veterinary surgeon or veterinary nurse if you are black or white; Muslim or Christian; and from any socioeconomic background.”
Sue's speech is available to read in full at www.rcvs.org.uk/features.
The Elekta Infinity linear accelerator is the only one of its kind for pets in England.
CVS says it allowing the centre to offer “cutting edge” image-guided radiation treatments for cancer in cats and dogs – meaning fewer, shorter sessions, fewer side effects and the best possible chance of improved outcomes for the animal.
Delphine Holopherne-Doran, Clinical Director at Bristol Vet Specialists, said: “Our new hospital is now at the forefront of cancer care in animals.
"We have invested in this state-of-the-art technology to bring cancer treatment in pets to the next level.
“Our unique linear accelerator allows us to offer advanced image-guided treatments - for example intensity-modulated or stereotactic radiation therapy.
"The advantage of these treatments is that high dose rates of focused beams are delivered with high precision over a shortened treatment course, with greater safety for the patient’s healthy tissue.
“It has now drawn many tumours into the realm of treatability, it is improving the quality of life for patients, and it is making it easier for owners to manage their pet’s treatment and aftercare.”
Still, the installation of the linear accelerator will probably have cost the same again, and then you've got the running costs.
That's not an inconsiderable cost per patient.
A study by Janssen Animal Health has, according to the company, demonstrated that a leading herbal wormer had no demonstrable efficacy against common poultry worms1.
The trial, done to Good Clinical Practice (GCP) Standards, involved 48 chickens that had become naturally infected with three different poultry worms - Capillaria (Hairworm) species, Heterakis gallinarum (Caecal worm) and Ascaridia galii (Large roundworm). The birds were randomly assigned to one of three groups:
A. Flubenvet treated groupB. Herbal wormer treated groupC. Control (untreated) group.
The herbal treatment was administered for 3 days in-feed, as required by the 'on-pack' instructions and Flubenvet was given for 7 days as required on the product data sheet. Droppings were collected from individual birds and group pens at intervals for 2 weeks and examined for the presence of worm eggs
Table 1: Worm Count Summaries
Group
Minimum
Maximum
Median
A (Flubenvet treatment)
0.00
19.00
B (Herbal treatment)
108.00
1327.00
425.00
C (no treatment)
74.00
958.00
302.00
The results showed that very few worm eggs were present after one 7-day treatment with Flubenvet. In contrast, those that had no treatment or the herbal treatment still had hundreds of worm eggs in their droppings, suggesting that there were still many adult egg-laying worms present inside the chickens.
Janssen says poultry keepers who rely on preparations like this particular natural wormer may well be building up problems, as the additional numbers of worm eggs in the environment add to the infection pressure and can result in greater worm burdens for their birds. Birds with high worm burdens are more likely to become ill.
According to the Veterinary Medicines Regulations 2009 any product making veterinary medicinal claims needs to be licensed by the Veterinary Medicines Directorate. A licensed product has to show proven efficacy and safety for the animal species involved. Licensed veterinary medicines can be identified by their Vm number, which is shown on-pack. Products termed 'nutritional supplements', that are not licensed do not require the manufacturer to produce any proof of efficacy or safety. It is often easy to buy such products 'off the shelf' because they are not subject to any controls. Any poultry keeper who cares about the health and welfare of the birds is advised to think carefully about their choice of wormer and to seek advice from a vet pharmacist or Suitably Qualified Person (SQP).
1 Evaluation of the efficacy of flubendazole in comparison with a herbal wormer in the treatment of naturally acquired infections of Ascaridia galli, Heterakis gallinarum, and intestinal Capillaria spp in Chickens, Janssen Animal Health
The Animal Medicines Distributors Association (AHDA) and the Animal Medicines Training Regulatory Authority (AMTRA) have both come out against the BVA's call for all anthelmintic medicines to be reclassified as POM-V, which would prevent them being prescribed by Suitably Qualified Persons (SQP).
Ian Scott, Secretary General of AHDA, said that instead of launching an attack on SQPs, the BVA should be working with them and animal owners to tackle anthelmintic resistance: "The BVA has written to the VMD to ask that all anthemintics be classified to POM-V only. This will monopolise the supply and distribution of anthelmintics for vets only. It effectively places the blame for anthelmintic resistance squarely on SQPs.
"An attempt by BVA to create a division between vets and SQPs demonstrates that the BVA is out of touch with its members.
"Both prescribing channels must work together to tackle the problem and AHDA has been working hard with vets at national and local level to ensure customers receive consistent, high quality, up-to-date and relevant advice from both channels.
"What is worrying is that the BVA attack also infers that farmer producers and equine owners are incapable of making decisions that not only affect their livelihood but cast doubt on their ability to care for their animals' welfare."
Meanwhile, Stephen Dawson, Secretary General of AMTRA said: "The large majority of SQPs deal with parasite control on a daily basis, having trained and been examined to a syllabus developed with BVA input. SQPs have to undertake compulsory continuing professional development, the majority of which includes good practice in parasite control. Therefore AMTRA has every confidence that qualified SQPs have excellent knowledge of parasitology to advise their clients on the correct choice and use of anthelmintics.
"It is important to recognise the hard work, knowledge and dedication of thousands of SQPs throughout the UK. The implication of what BVA say is that they are laying a proportion of the blame for resistance to these medicines at the door of SQPs. But the evidence isn't there: countries in Europe and elsewhere with different prescription systems, mainly though vet-only channels, still have major resistance problems. Prescription of antimicrobials by veterinary surgeons hasn't prevented concerns about prescribing practices and developing resistance. The key point is good advice from the prescriber and how they are then used in practice, rather than who prescribes them. The challenge for us all is not just to seek excellence in prescribing but also in usage on farm, something SQPs are ideally placed to do with their frequent farmer contact.
"I would urge all parties to work in partnership to ensure that best practice in prescription and use is followed by all prescribers and users. It is up to all prescribers to act responsibly, but to single out one group over another is unjustified. A pseudo-monopoly by vets on supply would do nothing to help farmers in difficult times."
Mr Dawson also expressed doubts about permanent POM-V status for new livestock anthelmintics: "While we fully support VMD's and VPC's need to be sure that the risk associated with wider availability of a new product is low, AMTRA considers that the current division in distribution classes and consequent low uptake of the newer products means that the much bigger risk is that widespread reliance on the three aging classes may be followed by reliance on just the two new classes when the older classes become unusable. Much better to have responsible prescription of all five classes now, by appropriately trained SQPs, vets and pharmacists, to ensure that there is a prospect of long term availability of effective parasite control."
Researchers from the University of Bristol have published the results of a study which has identified risk factors for syringomyelia (SM) and which could help breeders select away from characteristics which predispose dogs to the disease.
Syringomyelia, which more commonly affects toy breeds such as the Cavalier King Charles Spaniel and the Chihuahua, causes fluid-filled cavities in the spinal cord. In these toy breeds, SM is usually secondary to a specific malformation of the skull called Chiari-like Malformation (CM).
The research looked at the relationship between head shape and the incidence of CM/SM. Dogs were measured in several countries using a standardised "bony landmark" measuring system and photos analysed by researchers.
The researchers found two significant risk factors associated with CM/SM in the skull shape of the CKCS: brachycephaly (the broadness of the top of skull relative to its length) and the distribution of doming of the skull. The study suggests that brachycephaly, with resulting doming towards the front of the head, is associated with CM/SM.
Thomas Mitchell, the undergraduate student who conducted the study under the supervision of Dr Clare Rusbridge, said: "Dog breeders are very experienced at selecting for a certain conformation or appearance in dogs. Our findings may allow breeders to select away from the condition over fewer generations by choosing appropriate matings and offspring to continue breeding programmes. The identification of an appearance that might protect against developing the disease is a significant step forward in tackling this painful condition.
"The study also provides guidance to breed clubs, breeders and judges that have a responsibility to avoid obvious conditions or exaggerations which would be harmful in any way to the health, welfare or soundness of the breed. It will also provide vets with verified advice to provide to breeders outside the show ring and to occasional hobbyists."
The study has been published online in the journal Canine Genetics and Epidemiology, and a video animation which shows the differences in head shape is available on YouTube.
The work was funded by a grant from the Kennel Club Charitable Trust and the Companion Cavalier Club provided a grant for the publication of the research.
Royal Canin has announced that it has established a team of three specialist advisors to work directly with veterinary practices to help develop and improve their weight management clinics, client retention and product sales.
The Pet Weight Care Team will also provide practical training to all practice staff on how to recognise weight problems, communicate sensitively with pet owners and treat the problem effectively.
The first advisor to join the team is Shelley Holden VN (pictured right), who has 10 years' experience as the nurse for the Royal Canin Weight Management Referral Clinic at The University of Liverpool. Shelley has spent time running successful nursing clinics in general practice and lecturing internationally on the topic of obesity. She said: "I have spent many years dedicating my time caring for overweight pets, and the number of cases we see is continuing to rise. It's really important that as obesity specialists we can offer hands-on support to practices to assist them with helping to decrease the number of overweight pets they see.
"Our aim will be to offer specialist training through a number of sessions to practices who wish to improve their weight management clinics. We'll spend time with all members of staff helping them to feel more confident when dealing with owners who have overweight pets. The training will include all aspects of weight management including how to approach owners, Body Condition Scoring and the 30 minute consult. Staff will also be trained on how to support owners throughout the weight loss program and during the maintenance phase."
Royal Canin says the training will also cover the prevention of obesity in pets, how to advise owners on the appropriate diets post neutering and how to manage the animal's weight and calorie intake throughout their lives. The Pet Weight Care Team will be encouraging practices to carry out weight management assessments alongside medical examinations to ensure that potential weight problems are dealt with quickly.
The company says that practices that receive training will be followed up with on a regular basis to provide further support and training as needed.
For more information, contact your Royal Canin Veterinary Business Manager.
Zoetis Business Consulting has released figures showing that Profit Solver, its financial analysis tool, has delivered an average EBITDA (earnings before interest, taxes, depreciation and amortization) growth of 36% for the 28 UK practices that have used the new service since its launch.
Profit Solver was first launched in the USA, where the company says more than 300 practices have now benefited from the service.
Zoetis says that traditionally, veterinary practices have set their prices by simply adding a set mark-up, without knowing which services make a profit or loss and without understanding exactly how overall practice profit is being generated.
Profit Solver instead uses the practice’s own data to calculate the exact cost for the 130 most commonly performed veterinary services, representing 90% of the revenue generated by the practice. It then combines labour, inventory and equipment costs with time-and-motion studies for each service, and assesses the variance between cost and price to reveal profit or loss.
By using a collection of cost data, which staff perform which part of the procedure, how long the procedure takes and what equipment and materials are used, Profit Solver calculates the correct pricing to both cover costs and deliver a pre-determined profit margin.
Implementing Profit Solver is done with a Zoetis business consultant who guides the practice through the process, from data collection to examining the time-and-motion studies. They discuss the level of profitability the practice needs to deliver and help analyse prices to achieve this goal whilst preserving the price-point of highly competitive services and covering all the practice’s costs.
Ian Camm, Group Director of B&W Equine Vets in Gloucestershire heard about Profit Solver from a vet in a neighbouring practice who was impressed with how it had helped his business. Ian discussed Profit Solver with his Zoetis account manager and booked an appointment with Zoetis Business Consultant Anthea Pike who has helped him implement the software across B&W Equine Group.
He said: "Initially I was concerned that Profit Solver would suggest we put prices up where we felt that we would not be able to - people shop around for their veterinary services these days and many services are very price sensitive. The first stage in the process addressed this by looking at our figures, calculating the cost price for each procedure and then, by comparing with our fees charged, identified where we were losing money. The big question was whether we would be comfortable to increase our fees on loss-making procedures. The beauty of the system was that by looking at a large number of procedures which were done frequently, very small increases in fee would total to a significant improvement in the bottom line.
"The software has made us recognise where the real costs are and how to address these areas accordingly, for example we have identified that current stud packages are not profitable. One of the problems in arriving at true costs is the difficulty in accurately allocating time to various procedures when several different vets are involved or an expensive scanner is used, which can have a significant impact on the results. It’s early days, but I can already see the difference that Profit Solver could make to our bottom line and wouldn’t hesitate to recommend it providing the practice is prepared to make changes in light of the results. We are looking at improving our bottom line by a six figure sum over a 12 month period with what we hope, will be hardly noticeable price rises.”
For further information visit www.zoetis.co.uk/businessconsulting.
No need for movie star looks, but if you've got a particular knack for taking blood pressure readings and are happy to appear on screen, the company is offering feline goodies and £50 Love2Shop vouchers in return for your help. And who knows, it could be the start of a second career in Hollywood.
Ceva is also asking veterinary surgeons and nurses for their top tips for taking blood pressure in cats, with the information potentially being featured in the film and shared with veterinary practices across the country.
For further information, please contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.
The 4% increase was approved by the Privy Council and the Department for Environment, Food & Rural Affairs.
Dr Tshidi Gardiner, RCVS Treasurer, said: “As with last year, RCVS Council recognises that we are living in difficult economic times, and have tried to keep the fee increase to a minimum.
"However, it is important that we increase fees in line with inflation, as well as take into account additional related costs, to ensure we are fulfilling our regulatory remit to the best of our abilities and meet our strategic priorities.”
Veterinary surgeons need to pay their annual renewal by 1st April and will be sent their fee notices within the first two weeks of March.
Anyone who has not paid their fee by 1st May will incur a higher fee charge of £36, with non-payment by 1st June risking removal from the Register and ineligibility to practise.
As part of the annual renewal process, all individual vets will also need to log into their online MyAccount to confirm their registration and contact details and declare any convictions.
Anyone who expects to encounter any difficulties in paying their fees should contact the RCVS Finance Team on finance@rcvs.org.uk or 020 7202 0722.
Alstoe Animal Health has launched Dolagis, a carprofen tablet for dogs that uses a unique delivery system which the company claims offers palatability and dosage benefits over other versions of this analgesic.
Called Delicament, the delivery system is essentially a clever tablet design which allows a single table to break easily and accurately into four pieces. That allows correct dosing for all dogs above 3kg, from just one tablet size. Delicament has also been designed to be highly palatable, both in terms of flavour (pig's liver, before you ask) and texture.
To further simplify practice stocking requirements, Dolagis comes in only one pack size, complete with dispensing envelopes that explain how to split the tablet.
Dolagis 50mg tablets are packed in individually perforated blister strips of 10 tablets to aid prescribing accuracy and product integrity. This also reduces the chance that high palatability can lead to patient self-consumption. There are 100 tablets per Dolagis pack, which are available from all wholesalers. For further information contact Alstoe on 01347 878606 or email info@alstoe.co.uk.
Vet practices across the UK are being urged to get involved with Pet Smile Month to increase practice footfall and attract new clients in the tough economic climate.
Pet Smile Month, which runs during September 2009, is the world's largest veterinary-led pet health campaign and requires practices to offer a free dental check to pets by appointment during the month. The initiative aims to improve understanding of the importance of dental disease in dogs, cats and other pets and to encourage better dental care.
Over 1,500 UK practices have supported the campaign in recent years and some have reported increases of up to 10% in dental treatments in the months following the campaign. High profile sponsors; Pedigree, Whiskas, Petosan, Genitrix and Logic are supporting this year's Pet Smile Month.
There is no cost for participating and those practices which do will receive supplies of goody bags containing samples of Pedigree® DentaStixTM or Whiskas® DentaBitsTM, together with information leaflets, competitions and other special offers, to give to clients with their free dental health check.
Bob Partridge, the organiser of Pet Smile Month, is working with the sponsors on a major local radio publicity campaign at the end of August to raise awareness of Pet Smile Month and encourage pet owners to contact their local participating practice. The deadline to sign up is Monday 17 August 2009. Full details of how to get involved are available at www.petsmile.org or by calling 08714 24 25 26.
The Dogs Trust has released the results of its 2010 Stray Dog Survey, which shows that 51% of stray dogs picked up by local authorities in the UK were reunited with their owners.
According to the charity, this compares with 42% last year and is only the second time the figure has gone through the 50% barrier since survey records began in 1997.
Where the method used to return stray dogs was identified, the proportion of dogs returned through microchipping was 35% - up from 31% last year.
Dogs Trust is repeating the call for the introduction of a compulsory microchipping system for all dogs in the UK. It believes this will help reunite even more owners with their lost pets, trace abandoned pets back to irresponsible owners and ultimately reduce the number of healthy dogs unnecessarily put to sleep in the UK.
The annual Stray Dog Survey, conducted by GfK NOP on behalf of Dogs Trust, shows an overall increase in instances of straying from 107,228 to 121,693. However, taking into account the number of dogs reclaimed or returned to owner (45,329 in 2009 and 61,908 in 2010) we can estimate that this year the number of dogs actually abandoned (approximately 59,785) as opposed to being wanted pets that simply strayed has fallen by 3%.
There has been a considerable decline in the number of dogs being put to sleep by Local Authorities due to ill health, aggression (under the Dangerous Dogs Act) or simply for want of a home. Down from 9,310 in last year's survey to 6,404 this year. Dogs Trust is delighted at the progress Local Authorities have made in bringing down these numbers and their efforts in rehoming and returning so many dogs to their owners.
Dogs Trust Chief Executive Clarissa Baldwin said: "Dogs Trust is encouraged to see that although the instances of straying in the UK has increased in the last two years, the percentage of these dogs being reunited with their owners has increased and, more importantly, the numbers being put to sleep has fallen drastically.
"We are delighted to see that microchipping is having a serious impact on the stray dog situation in the UK. Dogs Trust runs subsidised microchipping campaigns across the country and in particular those areas with the biggest stray dog problems. A compulsory microchipping system would undoubtedly improve the situation further."
Dogs Trust says the introduction of compulsory microchipping would:
In addition to the UK, Vetigel will be marketed and distributed to veterinary surgeons throughout Europe and elsewhere via Veterinary Instrumentation's global distribution network.
Matt Lewis, Vice President of Sales at Cresilon said: "Our partnership with Veterinary Instrumentation will help us provide more veterinary surgeons with a revolutionary hemostatic gel that significantly improves the standard of care for pets and animals.
"Vetigel has been used by thousands of veterinarians thus far and helps veterinary clinics and animal hospitals save time, reduce operating costs, and improve patient outcomes."
https://vetigel.comhttps://veterinary-instrumentation.co.uk
The randomised controlled trial1 was conducted in 11 flocks with 6840 lambs during last year's lambing season (2023-2024), making it the largest ever navel protection study in the UK.
For the trial, odd numbered lambs were treated with strong iodine and even numbered lambs were treated with NoBACZ Navel.
Current practices on the farm were observed, so if the farmer normally dipped the lambs’ umbilicus they dipped with iodine or NoBACZ Navel and if they normally sprayed the umbilicus then they sprayed with iodine or NoBACZ Navel.
Survival and weights were recorded.
The study concluded that NoBACZ Navel demonstrated superior protection compared to iodine, with a 21% reduction in mortality (p=0.005).
On top of that, lambs that had NoBACZ Navel applied to the umbilicus and tagging sites were on average 230g heavier than those in the iodine group at eight weeks.
Fiona said: "Until now, best practice to manage navel ill has been to apply strong iodine to the umbilicus and ear-tagging sites by dipping or spraying to desiccate the umbilicus and disinfect the surface.
"Prophylactic antibiotic use also still occurs on as many as 19% of farms2, which is not best practice or good antimicrobial stewardship.
“NoBACZ Navel provides greater desiccation of the umbilicus than iodine and forms a non-colonisable waterproof barrier which protects lambs from the environment.
“The economic and welfare benefits to farmers are clear, with 17 more lambs alive per 1,000 born and an average of 230g extra bodyweight per lamb at eight weeks, which more than justifies the 16p per dose investment in NoBACZ Navel.
"During the trial I also received fantastic feedback from farmers on its ease of use and long-lasting protection to these vulnerable sites.”
www.nobacz.com
Following a nationwide search to find the UK’s top veterinary professionals for 2009 and judged by an independent panel of experts, Petplan has announced the winners for the Veterinary Awards.
The Petplan Veterinary Awards recognise and applaud staff and practices throughout the country that have delivered an exceptional level of care to the nation’s pets, and their owners.
Simon Wheeler, Petplan’s Head of Marketing, explains: “Britain is known to be an animal-loving nation and with millions of households owning cats and dogs, pets play a central part in family life. The Petplan Veterinary Awards give us the opportunity to thank the veterinary profession for the outstanding level of care they provide to our animals.”
The winners of the 10th annual Petplan Veterinary Awards were:
VET OF THE YEARBen Jones, Ben Jones Veterinary Surgery, Chester, FlintshireBen’s understanding and compassion for his clients’ pets impressed the judges. Whilst being extremely knowledgeable, Ben can reassuringly explain the most complicated procedures to clients. Ben continuously goes above and beyond the call of duty, such as establishing a home visit scheme for pensioners and visiting a nursing home when an owner was there as a day patient.
VET NURSE OF THE YEARKaren McQuoid, The Old Golfhouse Veterinary Group, Watton, NorfolkThe judges believe Karen is an excellent role model for her team of nurses. Karen was noted for her positive attitude and good humour even under extreme pressure of being head nurse of four different practices.
VET RECEPTIONIST OF THE YEAR Yasmin Morowa, Melton Veterinary Surgery, Woodbridge, SuffolkYasmin’s attention to detail made her stand out as the winner of Vet Receptionist of the Year. Yasmin always checks to see how patients have progressed when she returns from holiday so she can help clients appropriately when they call or visit. Her kind approach makes her highly appreciated by both clients and colleagues.
VET PRACTICE OF THE YEAR St Clair Veterinary Group, Kirkcaldy, FifeSt Clair Veterinary Group was described as having exceptional customer care and uses every opportunity to educate their clients. The team stood out for their environmental consciousness.